CVS Group

CVS Group plc is a British veterinary services business whose activities are centered on the ownership and operation of veterinary practices. The group emerged after a 1999 change to the Veterinary Surgeons Act 1966 permitted veterinary practices in the United Kingdom to be owned by non-veterinary surgeons. This regulatory change enabled outside investors and business operators to establish consolidated veterinary-services companies, rather than limiting practice ownership to veterinary professionals themselves. CVS Group was formed by a group of individuals in the period following that legislative change. Its growth model subsequently relied substantially on acquiring smaller veterinary practices around the United Kingdom and bringing them into a larger operating group. Simon Innis joined as chief executive in January 2004 and led the company during a major phase of expansion. Under this broader group structure, CVS developed from a collection of practices into a national veterinary-services business with a range of clinical and supporting operations. The company entered public markets through an initial public offering on the Alternative Investment Market of the London Stock Exchange in October 2007. Its public listing gave CVS access to capital for continued expansion and made it one of the more visible consolidators in the British veterinary sector. By 2020, it was described as the largest veterinary business in the United Kingdom. CVS’s scale also placed it within wider debates about consolidation, competition, ownership, pricing, and consumer choice in veterinary care. In February 2022, the Competition and Markets Authority expressed concerns relating to a proposed acquisition of the rival business The Vet, and the transaction was put on hold. The episode illustrated the increasing regulatory scrutiny applied to acquisitions in a sector where a relatively small number of groups control a substantial share of practices. By 2024, CVS Group and five other companies together owned approximately 60% of UK veterinary practices, according to the referenced account. This concentration made CVS an important participant in discussions about the structure of the veterinary market, although the available reference material does not provide detailed financial, practice-count, or service-line data. Richard Fairman, previously the company’s finance director, became chief executive in November 2019. CVS remained an active listed veterinary-services group and transferred from the Alternative Investment Market to the London Stock Exchange’s main market in January 2026. The company’s core identity is therefore that of a UK veterinary-services consolidator, combining practice ownership with related animal-care operations rather than a consumer packaged-goods brand.

CVS Group developed in the aftermath of a significant change to British veterinary regulation. In 1999, amendments associated with the Veterinary Surgeons Act 1966 allowed veterinary practices to be owned by people who were not veterinary surgeons. This opened the way for corporate ownership and investment in a sector that had historically been organized largely around individually owned practices. A group of individuals used the new legal environment as the basis for forming CVS Group. The company’s principal growth method became the acquisition of smaller veterinary practices in the United Kingdom. Rather than building every location from the ground up, CVS assembled a broader network by purchasing established local businesses and operating them within a common corporate structure. This approach reflected the wider consolidation of British veterinary care, in which larger groups could provide centralized management and access to capital while retaining local clinical operations. Simon Innis joined CVS as chief executive in January 2004. He led the company through much of its expansion and helped establish its position as a major UK veterinary-services operator. CVS reached a public-market milestone in October 2007, when it completed an initial public offering on the Alternative Investment Market of the London Stock Exchange. The listing supported the company’s continued development as an acquisitive veterinary group. By 2020, CVS Group was described as the largest veterinary business in the United Kingdom. Its scale increased the company’s importance in debates about market concentration and the commercial organization of veterinary care. Richard Fairman, formerly the group’s finance director, became chief executive in November 2019, succeeding Innis and taking responsibility for the next phase of the company’s development. The group’s acquisition strategy encountered regulatory scrutiny in 2022. The Competition and Markets Authority raised concerns about a proposed acquisition of The Vet, a competing veterinary business. The transaction was put on hold in February of that year. This episode showed that veterinary-practice consolidation had become a competition-policy issue, particularly as ownership became concentrated among several large operators. By 2024, CVS Group and five other companies were reported to own 60% of UK veterinary practices. The figure placed CVS within a highly consolidated national market, although the cited material does not identify CVS’s precise individual share. The company continued to operate as a veterinary-services group rather than a conventional consumer brand, with its activities based on practice ownership, clinical services, and related animal-health operations. In January 2026, CVS Group transferred from the Alternative Investment Market to the London Stock Exchange’s main market. This was the latest dated structural milestone identified in the supplied reference material. Detailed information on the company’s founding individuals, exact headquarters, financial performance, current practice portfolio, and current executive team beyond Richard Fairman is not established by the available sources.

• 2026

  Move to the London Stock Exchange main market

  [1]CVS Groupen.wikipedia.org

  CVS Group transferred its listing from AIM to the London Stock Exchange’s main market in January.

• 2022

  The Vet acquisition placed on hold

  [1]CVS Groupen.wikipedia.org

  Competition and Markets Authority concerns led to the proposed acquisition of The Vet being put on hold in February.

• 2020

  Identified as the UK's largest veterinary business

  [1]CVS Groupen.wikipedia.org

  CVS Group was described as the largest veterinary business in the United Kingdom.

• 2019

  Richard Fairman becomes chief executive

  [1]CVS Groupen.wikipedia.org

  Former finance director Richard Fairman took over as chief executive in November.

• 2007

  Initial public offering on AIM

  [1]CVS Groupen.wikipedia.org

  CVS Group completed an initial public offering on the Alternative Investment Market of the London Stock Exchange in October.

• 2004

  Simon Innis becomes chief executive

  [1]CVS Groupen.wikipedia.org

  Simon Innis joined CVS Group as chief executive in January and led the company through much of its subsequent acquisition-led growth.

• 1999

  Regulatory change enables non-veterinary ownership

  [1]CVS Groupen.wikipedia.org

  Changes associated with the Veterinary Surgeons Act 1966 allowed veterinary practices to be owned by non-veterinary surgeons, creating the legal environment in which CVS Group was formed.

A listed UK veterinary-services group positioned around the ownership, consolidation, and operation of veterinary practices and related animal-health activities.

• Veterinary services

  Veterinary practices

  CVS Group’s central operating activity is the ownership and operation of veterinary practices in the United Kingdom. The group grew by acquiring smaller practices and incorporating them into a larger corporate network. The available reference material does not provide a complete list of practice names, locations, or clinical specialties.

• Animal healthcare

  Related animal-health services

  The group is described as a veterinary services business with activities related to animal care and veterinary practice operations. Specific service brands, product ranges, and commercial formats are not detailed in the supplied reference material.

• 2026

  Transfer from AIM to the main marketStrategy

  Background

  After operating as a company listed on the Alternative Investment Market since its 2007 public offering, CVS Group changed its London Stock Exchange market classification.

  Action taken

  The company transferred to the London Stock Exchange’s main market in January 2026.

  Aftermath

  The move marked a change in listing venue and public-market status. The supplied reference does not provide further details about the rationale or financial effects.

  Source

• 2022

  Put the proposed acquisition of The Vet on holdM&A

  Background

  CVS Group proposed acquiring rival veterinary business The Vet during a period of increasing consolidation in UK veterinary care. The Competition and Markets Authority expressed competition concerns about the transaction.

  Action taken

  The proposed transaction was put on hold in February 2022.

  Aftermath

  The case became an example of regulatory scrutiny of acquisitions in the increasingly concentrated UK veterinary-services market. The supplied material does not establish a later final outcome.

  Source

1. 1CVS Groupen.wikipedia.org